article thumbnail

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

article thumbnail

PerkinElmer Life Sciences division becomes Revvity

Drug Discovery World

PerkinElmer’s Life Sciences division has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The company’s software platform, previously known as PerkinElmer Informatics, will become Revvity Signals Software, while Revvity Omics will replace PerkinElmer Genomics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PerkinElmer’s Life Science and Diagnostics business becomes Revvity

Drug Discovery World

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The post PerkinElmer’s Life Science and Diagnostics business becomes Revvity appeared first on Drug Discovery World (DDW).

article thumbnail

Up to 8 recipients to be awarded grants for genomic research

Drug Discovery World

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . Applications will be accepted until 15 December 2022. .

Genome 52
article thumbnail

Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China

The Pharma Data

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

article thumbnail

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China

The Pharma Data

(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52
article thumbnail

The latest drug discovery product launches

Drug Discovery World

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. DDW provides an update.